OMX Ventures describes itself as venture capital built for builders, by builders, focusing on companies at the intersection of biology and computation—backing AI-driven biology, bioengineering, and tech-bio platforms across both the U.S. and Europe. The fund often steps in as a founding or lead investor in deep-tech synthetic biology and bio-tools companies, and it also backs company-creation platforms like General Inception, which helps build new science-based companies from the ground up.